Publications by authors named "Thomas C Luke"

Claim this Profile
N
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model.
Douglas S Reed, Anita K McElroy, Dominique J Barbeau, Cynthia M McMillen, Natasha L Tilston-Lunel, Thomas C Luke

PLoS One· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin Swabbing for Staphylococcus aureus-Targeting Phages.
Christopher Duplessis, Thomas C Luke, Chase Watters, Yolanda Alcorta, Biswajit Biswas

Mil Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Antibody Avidity and Cross-Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Variants by Hyperimmunized Transchromosomic Bovine-Derived Human Immunoglobulins for Treatment of Coronavirus Disease 2019.
Juanjie Tang, Gabrielle Grubbs, Youri Lee, Hua Wu, Thomas C Luke

J Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants.
Zhuoming Liu, Hua Wu, Kristi A Egland, Theron C Gilliland, Matthew D Dunn, Thomas C Luke

Hum Vaccin Immunother· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays.
Brian J Morrison, Nicholas J Martin, Tauseef Rehman, Dan Ewing, Robin L Dewar, Thomas C Luke

BMC Health Serv Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial.
Janine R Danko, Tadeusz Kochel, Nimfa Teneza-Mora, Thomas C Luke, Kanakatte Raviprakash

Am J Trop Med Hyg· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy.
Brian J Morrison, Jessica A Roman, Thomas C Luke, Nishith Nagabhushana, Kanakatte Raviprakash

J Virol Methods· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity.
Bradley W Hickey, Joanne M Lumsden, Sharina Reyes, Martha Sedegah, Michael R Hollingdale, Thomas C Luke

Malar J· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle.
John M Dye, Hua Wu, Jay W Hooper, Surender Khurana, Ana I Kuehne, Thomas C Luke

Sci Rep· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol.
Yaseen Arabi, Hanan Balkhy, Ali H Hajeer, Abderrezak Bouchama, Frederick G Hayden, Thomas C Luke

Springerplus· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.
Gabriel N Defang, Nicholas J Martin, Timothy H Burgess, Eugene V Millar, LeNae A Pecenka, Thomas C Luke

PLoS One· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.
Gregory A Poland, Douglas M Fleming, John J Treanor, Eugene Maraskovsky, Thomas C Luke

Vaccine· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA.
Thomas L Richie, Yupin Charoenvit, Ruobing Wang, Judith E Epstein, Richard C Hedstrom, Thomas C Luke

Hum Vaccin Immunother· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study in scarlet-convalescent plasma for severe influenza*.
John H Beigel, Thomas C Luke

Crit Care Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hark back: passive immunotherapy for influenza and other serious infections.
Thomas C Luke, Arturo Casadevall, Stanley J Watowich, Stephen L Hoffman, John H Beigel

Crit Care Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protecting public health and global freight transportation systems during an influenza pandemic.
Thomas C Luke, Jean-Paul Rodrigue

Am J Disaster Med· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?
Thomas C Luke, Edward M Kilbane, Jeffrey L Jackson, Stephen L Hoffman

Ann Intern Med· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine.
Thomas C Luke, Stephen L Hoffman

J Exp Biol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.
Stephen L Hoffman, Lucy M L Goh, Thomas C Luke, Imogene Schneider, Thong P Le

J Infect Dis· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis